Trade Mark Journal No.2026/028 10 July 2026

WO0000001923294 (5)

Office of origin: United States of America

Date of International Registration:21 May 2026
Date of designation in the UK: 21 May 2026
Image for mark 1923294 MASS MEDICINES

International priority date claimed: 24 November 2025 (United States of America) (99512809)
Class 5
Pharmaceutical preparations, namely antibody-peptide conjugates for the treatment of chronic obesity and metabolic disorders.

Mass Medicines, Inc.

Representative: Shane Rumbaugh, 2400 Ansys Drive, Suite 102, Canonsburg PA 15317, UNITED STATES OF AMERICA